Fredag 16 Maj | 06:23:35 Europe / Stockholm

Kalender

Est. tid*
2025-10-31 07:00 Kvartalsrapport 2025-Q3
2025-07-11 07:00 Kvartalsrapport 2025-Q2
2025-04-30 - Kvartalsrapport 2025-Q1
2025-04-28 - X-dag ordinarie utdelning AKBM 0.00 NOK
2025-04-25 - Årsstämma
2025-02-12 - Bokslutskommuniké 2024
2024-11-01 - Kvartalsrapport 2024-Q3
2024-09-09 - X-dag ordinarie utdelning AKBM 45.00 NOK
2024-09-03 - Extra Bolagsstämma 2024
2024-07-12 - Kvartalsrapport 2024-Q2
2024-04-26 - Kvartalsrapport 2024-Q1
2024-04-17 - X-dag ordinarie utdelning AKBM 0.00 NOK
2024-04-16 - Årsstämma
2024-02-14 - Bokslutskommuniké 2023
2023-11-01 - Kvartalsrapport 2023-Q3
2023-07-14 - Kvartalsrapport 2023-Q2
2023-04-28 - Kvartalsrapport 2023-Q1
2023-04-21 - X-dag ordinarie utdelning AKBM 0.00 NOK
2023-04-20 - Årsstämma
2023-02-15 - Bokslutskommuniké 2022
2022-11-01 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-04-29 - Kvartalsrapport 2022-Q1
2022-04-21 - X-dag ordinarie utdelning AKBM 0.00 NOK
2022-04-20 - Årsstämma
2022-02-17 - Bokslutskommuniké 2021
2021-10-29 - Kvartalsrapport 2021-Q3
2021-07-14 - Kvartalsrapport 2021-Q2
2021-04-29 - Kvartalsrapport 2021-Q1
2021-03-15 - X-dag ordinarie utdelning AKBM 0.00 NOK
2021-03-12 - Årsstämma
2021-02-16 - Bokslutskommuniké 2020
2020-10-30 - Kvartalsrapport 2020-Q3
2020-07-15 - Kvartalsrapport 2020-Q2

Beskrivning

LandNorge
ListaOslo Bors
SektorHandel & varor
IndustriDagligvaror
Aker BioMarine är verksamma inom bioteknik. Bolaget är specialiserade inom utveckling av kostillskott. Produktportföljen är bred och inkluderar exempelvis omega-3 olja, näringstillskott för djur, samt proteintillskott för fiskeodling. Verksamheten drivs globalt med störst närvaro inom den nordiska marknaden. Kunderna består av både privata aktörer samt grossister. Aker BioMarine grundades år 2006 och har sitt huvudkontor i Oslo.
2020-11-03 14:22:37
Fornebu - November 3, 2020

Ola Snøve, Chairman of Aker BioMarine AS, purchased in the period from 30
October to 3 November 185 000 shares in Aker BioMarine AS at an average price of
NOK 81,9 per share through his wholly owned company Storbrea AS. The shares were
acquired on Merkur Market. Following the transaction, Snøve holds a total of 185
000 shares in Aker BioMarine AS.

Katrine Klaveness, Chief Financial Officer, purchased on 3 November 4 450 shares
in Aker BioMarine AS at an average price of NOK 83 per share. The shares were
acquired on Merkur Market. Following the transaction, Klaveness holds a total of
4 450 shares in Aker BioMarine AS.

Sigve Nordrum, EVP Animal Health and Nutrition, purchased on 30 October 4 600
shares in Aker BioMarine AS at an average price of NOK 80,90 per share. The
shares were acquired on Merkur Market. Following the transaction, Nordrum holds
a total of 5 600 shares in Aker BioMarine AS.

Shauna Mcneill, EVP Innovation, purchased on 30 October 4 870 shares in Aker
BioMarine AS at an average price of NOK 81,95 per share. The shares were
acquired on Merkur Market. Following the transaction, Mcneill holds a total of 4
870 shares in Aker BioMarine AS.

Tim de Haas, EVP Human Health and Nutrition, purchased on 30 October 4 650
shares in Aker BioMarine AS at an average price of NOK 81,95 per share. The
shares were acquired on Merkur Market. Following the transaction, de Haas holds
a total of 4 650 shares in Aker BioMarine AS.

Tone Lorentzen, EVP Supply Chain, purchased on 2 November 4 500 shares in Aker
BioMarine AS at an average price of NOK 83,80 per share. The shares were
acquired on Merkur Market. Following the transaction, Lorentzen holds a total of
4 500 shares in Aker BioMarine AS.


For further information, please contact:
Katrine Klaveness, CFO
Phone: +47 991 58 915

About Aker BioMarine:
Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company,
developing krill-based ingredients for nutraceutical, aquaculture, and animal
feed applications. The company’s fully transparent value chain stretches from
sustainable krill harvesting in pristine Antarctic waters through its Montevideo
logistics hub, Houston production plant, and all the way to customers around the
world. The company is dedicated to improving human and planetary health.